Previous 10 | Next 10 |
Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2022 Financial Results on March 22, 2023 PR Newswire SALT LAKE CITY , March 9, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: S...
Debunking the 3 Most Common Myths About Penny Stocks Penny stocks have long been a popular topic of debate in the world of investing. Often misunderstood and unfairly maligned, penny stocks have been the subject of a number of common myths and misconceptions that have led many investors t...
Health diagnostic company Sera Prognostics ( NASDAQ: SERA ) jumped ~62% pre-market Wednesday after announcing that its PreTRM test and physician care met the key goals in a study designed to evaluate its health benefits. The AVERT PRETERM TRIAL assessed infant health benefits when...
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL PR Newswire PreTRM® test-and-treat strategy demonstrates statistically and clinically significant improvement in neonatal health outcomes and hospital length-of-stay SALT LAKE CITY , ...
FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS PR Newswire – Sera's PreTRM® test-and-treat strategy helps build on Fors Marsh's commitment to investing in its empl...
SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA PREDICTING CLINICAL UTILITY AND COST EFFECTIVENESS OF THE PRETRM® TEST-AND-TREAT STRATEGY ACROSS DIVERSE POPULATIONS PR Newswire - Clinical and economic benefits of the PreTRM® test and treat strategy illustrated...
Sera Prognostics, Inc. (SERA) Q3 2022 Earnings Conference Call November 9, 2022, 05:00 PM ET Company Participants Peter DeNardo - CapComm Partners, IR Greg Critchfield - President and CEO Jay Moyes - CFO Conference Call Participants Patrick Donnelly -...
Sera Prognostics press release ( NASDAQ: SERA ): Q3 GAAP EPS of -$0.35. Revenue of $87,000 compared to $23,000 for the same period of 2021. Total operating expenses were $11.3 million, up from $9.5 million for the third quarter of 2021. For further detail...
SERA PROGNOSTICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , Nov. 9, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by pro...
Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2022 Financial Results on November 9 PR Newswire SALT LAKE CITY , Oct. 27, 2022 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), ...
News, Short Squeeze, Breakout and More Instantly...
Sera Prognostics Inc. Company Name:
SERA Stock Symbol:
NASDAQ Market:
Sera Prognostics Inc. Website:
2024-07-06 13:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION PR Newswire SALT LAKE CITY , July 1, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on ...